Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T20:01:12.205Z.
Calculation as of: 2026-10-06T20:01:12.205Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 29544bddba9647c45f1d116a926e76fce0232fba061b4e126f75ac7ab8440d73
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$821.54M
Price/FCF Ratio
N/A
TTM Avg
198.42
3Y Avg
198.42
5Y Avg
198.42
Market Cap
$832.12M
Price/FCF Ratio
N/A
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$840.18M
Price/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$859.05M
Price/FCF Ratio
10.82
TTM Avg
9.59
3Y Avg
14.15
5Y Avg
25.73
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | $838.16M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $821.54M | N/A | 198.42 | 198.42 | 198.42 |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $832.12M | N/A | 12.01 | 12.01 | 12.01 |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | N/A | 8.01 | 8.93 | 8.93 |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $840.18M | N/A | N/A | N/A | N/A |
| Jade Biosciences, Inc. (JBIO)vs › | $811.26M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $804.07M | 9.19 | 9.91 | 9.93 | 15.12 |
| Alumis Inc. (ALMS)vs › | $855.38M | N/A | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $859.05M | 10.82 | 9.59 | 14.15 | 25.73 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $788.23M | N/A | 424.04 | 254.96 | 216.79 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
